Log in to save to my catalogue

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activa...

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6488881

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia

About this item

Full title

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia

Publisher

England: John Wiley & Sons, Inc

Journal title

CNS neuroscience & therapeutics, 2019-05, Vol.25 (5), p.549-561

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Summary
Aims
Prenatal maternal immune activation (MIA) is associated with a risk to develop schizophrenia and affects dopamine systems in the ventral tegmental area (VTA), key region in the neurobiology of psychoses. Considering the well‐described sex differences in schizophrenia, we investigated whether sex affects MIA impact on dopamine sys...

Alternative Titles

Full title

The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6488881

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6488881

Other Identifiers

ISSN

1755-5930

E-ISSN

1755-5949

DOI

10.1111/cns.13087

How to access this item